FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Guanfacine Hydrochloride Tablet, Extended Release
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Actavis Pharma, Inc. (New 11/13/2025)

Company Contact Information:
800-545-8800

Presentation	Posting Date	Related Information
Guanfacine Hydrochloride, Tablet, Extended Release, 1 mg (NDC 0228-2850-11)	11/13/2025	A business decision was made to discontinue manufacture of the drug.
Guanfacine Hydrochloride, Tablet, Extended Release, 2 mg (NDC 0228-2851-11)	11/13/2025	A business decision was made to discontinue manufacture of the drug.
Guanfacine Hydrochloride, Tablet, Extended Release, 3 mg (NDC 0228-2853-11)	11/13/2025	A business decision was made to discontinue manufacture of the drug.
Guanfacine Hydrochloride, Tablet, Extended Release, 4 mg (NDC 0228-2855-11)	11/13/2025	A business decision was made to discontinue manufacture of the drug.